
Pristiq (desvenlafaxine succinate)
50 mg/1 · Extended-Release Tablet
By Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- NDC
- 0008-1211
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
- Marketing category
- NDA
Package sizes
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-14)NDC 0008-1211-14Available to order
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-30)NDC 0008-1211-30Available to order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-01)NDC 0008-1211-01Available to order
- 100 BLISTER PACK in 1 CARTON (0008-1211-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACKNDC 0008-1211-50Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

